Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, makes liquid handling research more accessible with the launch of the Biomek i3 Benchtop Liquid Handler.

Purpose-built for low- to medium-throughput workflows, the Biomek i3 Benchtop Liquid Handler delivers powerful automation in a compact, cost-effective format. Its grid-based deck design includes 15 standard and 5 flex positions, enabling flexible configuration to accommodate a wide range of labware and protocols. The instrument supports genomic applications such as synthetic biology, sequencing, epigenetics, gene expression, and high-throughput screening, as well as drug discovery workflows including cell-based assays, biochemical assays, ADME-Tox, and combination sequencing.

At the heart of the instrument is an 8-channel pipetting tool that lets you select up to 8 tips in a single sequence—minimizing tip waste and setup time. With a wide volume range of 1–1,000 µL, it handles everything from delicate low-volume assays to large-volume transfers with precision. The integrated gripper supports ANSI/SLAS-compliant labware, including lids, plates, and tip boxes, ensuring seamless movement and compatibility across your workflow.

“This marks a natural evolution of the award-winning Biomek Liquid Handling platform, extending its powerful capabilities to a broader range of laboratories,” says Crystal Girod, Product Manager. “We listen closely to our customers, and their feedback helped us deeply understand the space and budget limitations many smaller labs face. In response, we developed an affordable, high-performance solution that empowers them with robust liquid handling capabilities to drive groundbreaking research. With intuitive software, a user-friendly interface, and no prior automation experience required, lab teams can automate complex workflows effortlessly—freeing them to focus on innovation and discovery rather than wrestling with complicated programming.”

Designed for on- and off-deck compatibility, the instrument supports heating, cooling, shaking, tilting, and thermocycling—enabling automation of complex protocols and enhancing process control without manual intervention. A large touchscreen interface with drag-and-drop functionality simplifies operation, while the MyBeckman Learning platform and a library of downloadable demonstrated methods support users with no prior liquid handling experience.

“Our productivity in the lab has increased dramatically with the addition of the Biomek i3 liquid handler,” says Brian Gorre-Clancy, Scientist, Assay Development and Automation at Archer Daniels Midland. “Our larger Biomek i7 system is freed up to do what it was designed for, and the Biomek i3 instrument gives us an accessible means to use automation during development on a lab bench scale.”

Product not intended or validated for use in the diagnosis of disease or other conditions.

About Beckman Coulter Life Sciences

Time is the most critical facet in the laboratory today:  time to get life-saving therapies to patients faster; reclaiming time by automating tedious manual workflows; and saving time otherwise spent addressing erroneous or complex results.

At Beckman Coulter Life Sciences, a Danaher company, we are partners in time. We accelerate answers to critical questions through the power of efficiency, saving hours from some workflows and delivering reliable results in centrifugation, flow cytometry, genomic solutions, particle analysis/counters, and liquid handlers.

We develop innovations for scientists by scientists, with many of our 3,300+ global colleagues coming from the laboratory with a deep understanding of today’s challenges and complexities. We’re passionate about translating science in partnership with our customers, and our customizable, accessible and sustainable solutions empower them with intuitive workflow efficiencies.

Time and again customers put their trust in us, with 400,000+ of our built-to-last products currently delivering results in labs worldwide – all backed by our dependable service and application experts offering educational insights and tailored support.

It’s all part of our time-tested approach since 1935 to bring meaningful innovations at the speed of life—and we’re just beginning. Working together, let’s advance human health for a better tomorrow!

About Danaher

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology—and proven ability to innovate—help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.